76 results
424B3
TRVN
Trevena Inc
23 Jan 24
Prospectus supplement
4:15pm
in patients with renal impairment, a large patient population with significant medical complications. The U.S. Drug Enforcement Administration has classified
8-K
EX-99.1
ttdk5qniu1eb
30 Mar 23
Trevena Announces Initial Topline OLINVYK Data from
7:08am
8-K
EX-99.2
1z6tlv1e
30 Mar 23
Trevena Reports Fourth Quarter 2022 Results and Provides Business Update
7:06am
424B5
ddzj 74z0oyokfxt
17 Nov 22
Prospectus supplement for primary offering
9:49pm
424B5
8fnybv
29 Jul 22
Prospectus supplement for primary offering
4:24pm